RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 82 filers reported holding RECRO PHARMA INC in Q2 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $319,000 | -96.6% | 70,212 | -93.6% | 0.21% | -95.7% |
| Q1 2020 | $9,300,000 | -54.1% | 1,104,546 | 0.0% | 4.84% | -38.7% |
| Q4 2019 | $20,246,000 | +65.4% | 1,104,546 | 0.0% | 7.90% | +38.0% |
| Q3 2019 | $12,238,000 | +8.9% | 1,104,546 | 0.0% | 5.72% | +6.4% |
| Q2 2019 | $11,233,000 | +80.1% | 1,104,546 | +3.8% | 5.38% | +31.7% |
| Q1 2019 | $6,238,000 | +0.7% | 1,064,546 | +22.0% | 4.08% | +12.2% |
| Q4 2018 | $6,195,000 | +84.0% | 872,494 | +84.3% | 3.64% | +14.9% |
| Q3 2018 | $3,366,000 | +71.4% | 473,484 | +21.0% | 3.17% | +135.6% |
| Q2 2018 | $1,964,000 | +160.8% | 391,307 | +472.3% | 1.34% | +209.7% |
| Q1 2018 | $753,000 | – | 68,370 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |